Abstract

The use of gene expression-based classifiers has resulted in a number of promising potential signatures of patient diagnosis, prognosis, and response to therapy. However, these approaches have also created difficulties in trying to use gene expression alone to predict a complex trait. A practical approach to this problem is to integrate existing biological knowledge with gene expression to build a composite predictor. We studied the problem of predicting radiation sensitivity within human cancer cell lines from gene expression. First, we present evidence for the need to integrate known biological conditions (tissue of origin, RAS, and p53 mutational status) into a gene expression prediction problem involving radiation sensitivity. Next, we demonstrate using linear regression, a technique for incorporating this knowledge. The resulting correlations between gene expression and radiation sensitivity improved through the use of this technique (best-fit adjusted R2 increased from 0.3 to 0.84). Overfitting of data was examined through the use of simulation. The results reinforce the concept that radiation sensitivity is not driven solely by gene expression, but rather by a combination of distinct parameters. We show that accounting for biological heterogeneity significantly improves the ability of the model to identify genes that are associated with radiosensitivity.

Highlights

  • One of the goals of developing biomarkers is for use in patient selection, diagnosis, and management of cancer treatment [1,2,3]

  • We had developed a successful mathematical model correlating gene expression and radiosensitivity, we reasoned the model had a number of problems that if overcome would significantly improve its ability to impact the field of radiation biology

  • We hypothesized that increasing the cell line dataset to 48 cell lines would result in a more accurate model

Read more

Summary

Introduction

One of the goals of developing biomarkers is for use in patient selection, diagnosis, and management of cancer treatment [1,2,3]. Designing the radiation therapy to maximize cancer cell death is beneficial, and predicting such a response of the cells to radiation therapy is important for effective patient management. Genes such as RAS [4, 5] and p53 [6] have been known to influence the response of tumor cells to radiation treatment. The SF2 (survival fraction of cells after 2 Gy of radiation) of melanoma and glioma cell lines has been shown to be higher (radioresistant) than lymphoma and myeloma cell lines [7,8,9]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call